
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $1.7B | $1.8B | $2B | $2.1B | $2.2B | |
Revenue Growth (YoY) | 2.25% | 5.97% | 13.6% | 6.37% | 1.98% | |
Cost of Revenues | $1.2B | $1.3B | $1.3B | $1.4B | $1.5B | |
Gross Profit | $474.4M | $517.8M | $687.7M | $747.5M | $713.3M | |
Gross Profit Margin | 28.27% | 29.12% | 34.05% | 34.79% | 32.55% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $46.9M | $52.9M | $58.8M | $58.6M | $56.5M | |
Other Inc / (Exp) | $5.9M | $255.1M | $172.9M | $31.2M | $56.7M | |
Operating Expenses | $46.9M | $52.9M | $58.8M | $58.6M | $56.5M | |
Operating Income | $427.5M | $464.9M | $628.9M | $688.9M | $656.8M | |
Net Interest Expenses | $167.6M | $156.9M | $154.7M | $149.2M | $168.5M | |
EBT. Incl. Unusual Items | $265.8M | $563.1M | $647M | $570.8M | $544.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $3.3M | $13.6M | -$6.2M | $4.7M | $5.2M | |
Net Income to Company | $264M | $550.7M | $654.8M | $567.8M | $541.6M | |
Minority Interest in Earnings | -$9.1M | -$16.9M | -$17.3M | -$15M | -$14M | |
Net Income to Common Excl Extra Items | $255M | $533.8M | $637.4M | $552.8M | $527.5M | |
Basic EPS (Cont. Ops) | $2.20 | $4.62 | $5.49 | $4.71 | $4.49 | |
Diluted EPS (Cont. Ops) | $2.19 | $4.61 | $5.48 | $4.71 | $4.49 | |
Weighted Average Basic Share | $114.2M | $114.7M | $115.3M | $116.5M | $116.8M | |
Weighted Average Diluted Share | $114.5M | $114.7M | $115.6M | $116.6M | $116.8M | |
EBITDA | $945.1M | $1.3B | $1.3B | $1.3B | $1.3B | |
EBIT | $433.4M | $720M | $801.7M | $720.1M | $713.4M | |
Revenue (Reported) | $1.7B | $1.8B | $2B | $2.1B | $2.2B | |
Operating Income (Reported) | $427.5M | $464.9M | $628.9M | $688.9M | $656.8M | |
Operating Income (Adjusted) | $433.4M | $720M | $801.7M | $720.1M | $713.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $425M | $476.1M | $529M | $543.6M | $549.3M | |
Revenue Growth (YoY) | 1.65% | 12.02% | 11.12% | 2.76% | 1.04% | |
Cost of Revenues | $306.9M | $319.7M | $339.2M | $360.8M | $374.3M | |
Gross Profit | $118.1M | $156.4M | $189.8M | $182.8M | $175M | |
Gross Profit Margin | 27.79% | 32.85% | 35.88% | 33.63% | 31.86% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $13M | $16.3M | $15.9M | $17M | $15.6M | |
Other Inc / (Exp) | -$15.9M | $10.8M | $3.5M | $23.5M | $72.7M | |
Operating Expenses | $13M | $16.3M | $15.9M | $17M | $15.6M | |
Operating Income | $105.1M | $140.1M | $173.9M | $165.8M | $159.4M | |
Net Interest Expenses | $39.7M | $39.1M | $37.3M | $40.4M | $45.2M | |
EBT. Incl. Unusual Items | $49.5M | $111.8M | $140.1M | $148.9M | $187M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $999K | -$1.4M | $944K | $1.8M | $1M | |
Net Income to Company | $48.9M | $113.6M | $139.6M | $147.6M | $186.4M | |
Minority Interest in Earnings | -$1.7M | -$2.8M | -$3.7M | -$3.9M | -$4.7M | |
Net Income to Common Excl Extra Items | $47.2M | $110.8M | $135.9M | $143.7M | $181.7M | |
Basic EPS (Cont. Ops) | $0.40 | $0.95 | $1.16 | $1.22 | $1.55 | |
Diluted EPS (Cont. Ops) | $0.40 | $0.95 | $1.16 | $1.22 | $1.54 | |
Weighted Average Basic Share | $114.3M | $115.3M | $116.2M | $116.7M | $116.8M | |
Weighted Average Diluted Share | $114.6M | $115.7M | $116.4M | $116.8M | $117.1M | |
EBITDA | $221M | $284.9M | $316.2M | $332.5M | $384.7M | |
EBIT | $89.2M | $150.9M | $177.4M | $189.3M | $232.1M | |
Revenue (Reported) | $425M | $476.1M | $529M | $543.6M | $549.3M | |
Operating Income (Reported) | $105.1M | $140.1M | $173.9M | $165.8M | $159.4M | |
Operating Income (Adjusted) | $89.2M | $150.9M | $177.4M | $189.3M | $232.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1.7B | $1.8B | $2.1B | $2.2B | $2.2B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $1.2B | $1.3B | $1.4B | $1.4B | $1.5B | |
Gross Profit | $468.6M | $556M | $721.1M | $740.5M | $705.5M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $46.6M | $56.2M | $58.4M | $59.7M | $55.1M | |
Other Inc / (Exp) | $18.9M | $281.9M | $165.6M | $51.2M | $105.9M | |
Operating Expenses | $46.6M | $56.2M | $58.4M | $59.7M | $55.1M | |
Operating Income | $422M | $499.8M | $662.7M | $680.8M | $650.4M | |
Net Interest Expenses | $163.8M | $156.3M | $152.9M | $152.3M | $173.3M | |
EBT. Incl. Unusual Items | $277.2M | $625.4M | $675.4M | $579.6M | $582.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $3.7M | $11.2M | -$3.8M | $5.6M | $4.5M | |
Net Income to Company | $274.9M | $615.4M | $680.8M | $575.9M | $580.4M | |
Minority Interest in Earnings | -$9.4M | -$18M | -$18.2M | -$15.2M | -$14.9M | |
Net Income to Common Excl Extra Items | $265.5M | $597.4M | $662.5M | $560.6M | $565.5M | |
Basic EPS (Cont. Ops) | $2.29 | $5.16 | $5.70 | $4.77 | $4.81 | |
Diluted EPS (Cont. Ops) | $2.29 | $5.16 | $5.70 | $4.77 | $4.80 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $957.8M | $1.3B | $1.4B | $1.3B | $1.4B | |
EBIT | $440.9M | $781.7M | $828.3M | $731.9M | $756.3M | |
Revenue (Reported) | $1.7B | $1.8B | $2.1B | $2.2B | $2.2B | |
Operating Income (Reported) | $422M | $499.8M | $662.7M | $680.8M | $650.4M | |
Operating Income (Adjusted) | $440.9M | $781.7M | $828.3M | $731.9M | $756.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $425M | $476.1M | $529M | $543.6M | $549.3M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $306.9M | $319.7M | $339.2M | $360.8M | $374.3M | |
Gross Profit | $118.1M | $156.4M | $189.8M | $182.8M | $175M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $13M | $16.3M | $15.9M | $17M | $15.6M | |
Other Inc / (Exp) | -$15.9M | $10.8M | $3.5M | $23.5M | $72.7M | |
Operating Expenses | $13M | $16.3M | $15.9M | $17M | $15.6M | |
Operating Income | $105.1M | $140.1M | $173.9M | $165.8M | $159.4M | |
Net Interest Expenses | $39.7M | $39.1M | $37.3M | $40.4M | $45.2M | |
EBT. Incl. Unusual Items | $49.5M | $111.8M | $140.1M | $148.9M | $187M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $999K | -$1.4M | $944K | $1.8M | $1M | |
Net Income to Company | $48.9M | $113.6M | $139.6M | $147.6M | $186.4M | |
Minority Interest in Earnings | -$1.7M | -$2.8M | -$3.7M | -$3.9M | -$4.7M | |
Net Income to Common Excl Extra Items | $47.2M | $110.8M | $135.9M | $143.7M | $181.7M | |
Basic EPS (Cont. Ops) | $0.40 | $0.95 | $1.16 | $1.22 | $1.55 | |
Diluted EPS (Cont. Ops) | $0.40 | $0.95 | $1.16 | $1.22 | $1.54 | |
Weighted Average Basic Share | $114.3M | $115.3M | $116.2M | $116.7M | $116.8M | |
Weighted Average Diluted Share | $114.6M | $115.7M | $116.4M | $116.8M | $117.1M | |
EBITDA | $221M | $284.9M | $316.2M | $332.5M | $384.7M | |
EBIT | $89.2M | $150.9M | $177.4M | $189.3M | $232.1M | |
Revenue (Reported) | $425M | $476.1M | $529M | $543.6M | $549.3M | |
Operating Income (Reported) | $105.1M | $140.1M | $173.9M | $165.8M | $159.4M | |
Operating Income (Adjusted) | $89.2M | $150.9M | $177.4M | $189.3M | $232.1M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $25.2M | $54.3M | $38.7M | $41.3M | $43M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $35.6M | $130.6M | $61.1M | $55.1M | $64.5M | |
Property Plant And Equipment | -- | -- | -- | -- | -- | |
Long-Term Investments | $43.3M | $42.8M | $42.3M | $42M | $41.7M | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | $1.3M | -- | -- | -- | -- | |
Other Long-Term Assets | $190.8M | $255.7M | $193.9M | $245.5M | $232.4M | |
Total Assets | $11.2B | $11.3B | $11.2B | $11.5B | $11.8B | |
Accounts Payable | -- | -- | $102M | $94.5M | $124.8M | |
Accrued Expenses | $528.3M | $584.4M | $69.3M | $71.4M | $95.6M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $700.3M | $584.4M | $558M | $1.1B | $856.7M | |
Long-Term Debt | $4.4B | $4.5B | $4.4B | $4B | $4.7B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $5.1B | $5.1B | $5B | $5.2B | $5.7B | |
Common Stock | $16.5M | $31.3M | $21.8M | $20.3M | $23.4M | |
Other Common Equity Adj | -$12.1M | -$11.1M | -$10.1M | -$8.8M | -$6.9M | |
Common Equity | $5.9B | $6B | $6B | $6.1B | $6B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $216.8M | $188.7M | $184.7M | $185.9M | $183.3M | |
Total Equity | $6.1B | $6.2B | $6.2B | $6.3B | $6.1B | |
Total Liabilities and Equity | $11.2B | $11.3B | $11.2B | $11.5B | $11.8B | |
Cash and Short Terms | $25.2M | $54.3M | $38.7M | $41.3M | $43M | |
Total Debt | $4.6B | $4.5B | $4.4B | $4.5B | $5B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $32.6M | $60.4M | $142.4M | $54.6M | $55.8M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $43.4M | $72.6M | $156M | $68.1M | $69.5M | |
Property Plant And Equipment | -- | -- | -- | -- | -- | |
Long-Term Investments | $43.2M | $42.7M | $42.3M | $41.9M | $41.8M | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $188M | $253M | $196.6M | $258.4M | $236.6M | |
Total Assets | $11.2B | $11.2B | $11.4B | $11.5B | $11.8B | |
Accounts Payable | -- | -- | -- | -- | -- | |
Accrued Expenses | $497.4M | $531.4M | $566.1M | $569.8M | $611.9M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $882.4M | $551.4M | $566.1M | $804.8M | $921.9M | |
Long-Term Debt | $4.3B | $4.5B | $4.4B | $4.4B | $4.7B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $5.2B | $5.1B | $5B | $5.2B | $5.7B | |
Common Stock | $19M | $28M | $20.8M | $20.3M | $25.6M | |
Other Common Equity Adj | -$11.9M | -$10.9M | -$9.8M | -$8.3M | -$6.5M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $214.8M | $183.4M | $187.6M | $184.9M | $183.8M | |
Total Equity | $6B | $6.1B | $6.4B | $6.3B | $6.2B | |
Total Liabilities and Equity | $11.2B | $11.2B | $11.4B | $11.5B | $11.8B | |
Cash and Short Terms | $32.6M | $60.4M | $142.4M | $54.6M | $55.8M | |
Total Debt | $4.7B | $4.5B | $4.4B | $4.6B | $5B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $264M | $550.7M | $654.8M | $567.8M | $541.6M | |
Depreciation & Amoritzation | $511.7M | $534.4M | $544M | $565.9M | $586.4M | |
Stock-Based Compensation | $14.3M | $16.7M | $18.8M | $15.7M | $15.8M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $823.9M | $895M | $1.1B | $1.1B | $1.1B | |
Capital Expenditures | $225.5M | $511.3M | $296.2M | $341.2M | $322.4M | |
Cash Acquisitions | -$5.3M | -$4.7M | -$13.8M | -$16.6M | -$2.9M | |
Cash From Investing | -$484.7M | -$253.6M | -$405.2M | -$775.3M | -$825.5M | |
Dividends Paid (Ex Special Dividend) | -$461M | -$474.1M | -$543.3M | -$655.4M | -$690.6M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $804.6M | $594.4M | -- | -- | $1.1B | |
Long-Term Debt Repaid | -$696.1M | -$467.2M | -$126.4M | -$353.9M | -$400M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$21.6M | -$28.2M | -$74.2M | -$38.7M | -$28.4M | |
Cash From Financing | -$374.1M | -$546.4M | -$722.8M | -$367.9M | -$271.1M | |
Beginning Cash (CF) | $70.5M | $35.6M | $130.6M | $61.1M | $55.1M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$34.9M | $95M | -$69.5M | -$6M | $1.7M | |
Ending Cash (CF) | $35.6M | $130.6M | $61.1M | $55.1M | $56.8M | |
Levered Free Cash Flow | $598.4M | $383.7M | $762.3M | $796M | $775.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $48.9M | $113.6M | $139.6M | $147.6M | $186.4M | |
Depreciation & Amoritzation | $131.8M | $134M | $138.8M | $143.3M | $152.5M | |
Stock-Based Compensation | $5.4M | $6.6M | $5.6M | $5.9M | $5.3M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $148.1M | $179.6M | $218.3M | $200.3M | $196.6M | |
Capital Expenditures | $49.2M | $38.2M | $75.6M | $52.1M | $72.6M | |
Cash Acquisitions | -- | -$7.5M | -$1.3M | -$750K | -$3.7M | |
Cash From Investing | -$112.5M | -$83.5M | -$138.4M | -$93M | -$61.4M | |
Dividends Paid (Ex Special Dividend) | -$118.2M | -$126.4M | -$162.6M | -$172.5M | -$178M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $213M | -- | -- | $346.6M | -- | |
Long-Term Debt Repaid | -$119.2M | -$343K | -$20.4M | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$3.5M | -$47.5M | -$6.1M | -$8.6M | -$4.9M | |
Cash From Financing | -$27.9M | -$154.1M | $15M | -$94.3M | -$122.5M | |
Beginning Cash (CF) | $35.6M | $130.6M | $61.1M | $55.1M | $56.8M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $7.8M | -$58M | $94.9M | $13M | $12.7M | |
Ending Cash (CF) | $43.4M | $72.6M | $156M | $68.1M | $69.5M | |
Levered Free Cash Flow | $98.9M | $141.4M | $142.7M | $148.2M | $124M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $274.9M | $615.4M | $680.8M | $575.9M | $580.4M | |
Depreciation & Amoritzation | $516.8M | $536.6M | $548.8M | $570.4M | $595.7M | |
Stock-Based Compensation | $14.4M | $17.9M | $17.7M | $16M | $15.2M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $811.5M | $926.5M | $1.1B | $1.1B | $1.1B | |
Capital Expenditures | $190.1M | $500.3M | $333.6M | $317.7M | $342.9M | |
Cash Acquisitions | -$4.4M | -$12.2M | -$7.6M | -$16.1M | -$5.8M | |
Cash From Investing | -$507.2M | -$224.6M | -$460.1M | -$729.9M | -$793.9M | |
Dividends Paid (Ex Special Dividend) | -$464M | -$482.3M | -$579.5M | -$665.3M | -$696.1M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $887.6M | -- | -- | $346.6M | $745.1M | |
Long-Term Debt Repaid | -$713.5M | -$348.3M | -$146.4M | -$593.5M | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$19.9M | -$72.2M | -$32.7M | -$41.3M | -$24.6M | |
Cash From Financing | -$309.9M | -$672.6M | -$553.7M | -$477.2M | -$299.4M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$5.7M | $29.2M | $83.4M | -$87.9M | $1.4M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $621.3M | $426.2M | $763.6M | $801.4M | $751.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $48.9M | $113.6M | $139.6M | $147.6M | $186.4M | |
Depreciation & Amoritzation | $131.8M | $134M | $138.8M | $143.3M | $152.5M | |
Stock-Based Compensation | $5.4M | $6.6M | $5.6M | $5.9M | $5.3M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $148.1M | $179.6M | $218.3M | $200.3M | $196.6M | |
Capital Expenditures | $49.2M | $38.2M | $75.6M | $52.1M | $72.6M | |
Cash Acquisitions | -- | -$7.5M | -$1.3M | -$750K | -$3.7M | |
Cash From Investing | -$112.5M | -$83.5M | -$138.4M | -$93M | -$61.4M | |
Dividends Paid (Ex Special Dividend) | -$118.2M | -$126.4M | -$162.6M | -$172.5M | -$178M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $213M | -- | -- | $346.6M | -- | |
Long-Term Debt Repaid | -$119.2M | -$343K | -$20.4M | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$3.5M | -$47.5M | -$6.1M | -$8.6M | -$4.9M | |
Cash From Financing | -$27.9M | -$154.1M | $15M | -$94.3M | -$122.5M | |
Beginning Cash (CF) | $35.6M | $130.6M | $61.1M | $55.1M | $56.8M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $7.8M | -$58M | $94.9M | $13M | $12.7M | |
Ending Cash (CF) | $43.4M | $72.6M | $156M | $68.1M | $69.5M | |
Levered Free Cash Flow | $98.9M | $141.4M | $142.7M | $148.2M | $124M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.